How to Apply

UK Myeloma Society
Award of Bursaries to IMS 2025
22nd Annual Meeting & Exposition 
17-20 September 2025, Toronto

Applications have now closed

We are encouraging all healthcare professionals to apply
(Such as nurses, pharmacists, allied healthcare professionals and doctors)

The UKMS is pleased to announce that there will be total of two bursaries available to attend ASH 2024. We are encouraging all allied healthcare professionals to apply. Applicants must be UK based and must be members of the UKMS. If you are not currently a member, please register via our website, a link can be found here. Membership is free. 

Applicants must be either the first or last author. Or, if neither, please specifically state your substantial contribution to this work in order to justify the bursary. Applicants will be required to provide a screenshot or invoice to indicate whether registering virtually or in person. It would be helpful if you could please notify the Judges in your covering letter if your abstract has been accepted. Bursaries are for travel to and from the meeting, registration and accommodation.  Bursaries can be claimed on return of all receipts after attending the meeting/conference.

Travel grant winners will be selected by a panel of from the UKMS Executive Committee. Please do not apply if you have been awarded a UKMS (formally UKMF) bursary in the last two years. Successful applicants will be required to complete the tasks set out below:

Number of bursaries to be awarded  Eligible Group  Application Criteria Tasks to be completed if successful  Value of award

2

All allied healthcare professionals.  Including, scientists, nurses, pharmacists, clinicians and other investigators submitting an abstract to ASH relevant to Myeloma Abstract submitted to ASH to be forwarded to UKMS
  • Present your abstract at the UKMS Spring Day on Wednesday 19 March 2025
  • Write a review for the UKMS website and e-newsletter by January 2025.
Up to £1,200 each

Funding has kindly been provided by the Michael Morley Fund and our Premium sponsors, Amgen, Janssen, The Binding Site, Menarini Stemline and Sanofi, who we thank for their continued support.

Applications:

All Applications must include a cover letter or e-mail with details of:

  • Name
  • Current position or job title
  • Place of work, with department, address and contact details
  • Please do not apply if you have been awarded a UKMS bursary in the last 2 years.

Those who are submitting an abstract to the 66th Annual Meeting of the American Society of Haematology and wish to be considered for any of these grants should submit their abstract electronically to Wendy (wendy@ukms.org.uk), by 5pm on Tuesday 1 October 2024. 

All submissions will be judged by a panel of members of the UKMS Executive Committee and applicants will be notified of the outcome of the competition by mid-October 2024.

Please note that if you are unable to present your work, then the UKMS reserve the right to withdraw the bursary.

UK Myeloma Society
Award of Bursaries to EHA Congress 2024
13-16 June 2024, Madrid

The UK Myeloma Society (UKMS) is pleased to announce that there will be total of 2 bursaries available either virtually or person attend EHA Congress 2024 in Madrid. All applicants must be UK based and must be members of the UK Myeloma Society. If you are not currently a member, please register via our website, a link can be found here. Membership is free.

Applicants must be either the first or last author. Or, if neither, please specifically state your substantial contribution to this work in order to justify the bursary.

Travel grant winners will be selected by a panel of from the UKMS Executive Committee. Please do not apply if you have been awarded a UKMS (formally UKMF) bursary in the last two years. Successful applicants will be required to complete the tasks set out below:

Number of bursaries to be awarded Eligible Group Application CriteriaTasks to be completed if successful  Value of award

2

Scientists, nurses, pharmacists, clinicians and other investigators submitting an abstract to EHA relevant to MyelomaAbstract submitted to EHA to be forwarded to UKMS
  • Present your abstract at the UKMS Spring Day on Wednesday 20 March 2024 (Central London)
  • Write a review for the UKMS website and e-newsletter by July 2024.
  • Indicate whether virtual or in person attendance at time of accepting bursary.
Up to £900 each

Funding has kindly been provided by the Michael Morley Fund and our Platinum sponsors, Amgen, The Binding Site, GSK, Janssen, Menarini Stemline, who we thank for their continued support. 

Applications:

All Applications must include a cover letter or e-mail with details of:

  • Name
  • Current position or job title
  • Place of work, with department, address and contact details
  • Please do not apply if you have been awarded a UKMS (formally UKMF) bursary in the last 2 years.
  • Applicants must be either first or last author.
  • It would be helpful to let the judges know if your abstract has been accepted.

Those who are submitting an abstract to EHA Congress and wish to be considered for any of these grants should submit their abstract electronically to Wendy (wendy@ukms.org.uk), by 5pm on Wednesday 6 March 2024. 

All submissions will be judged by a panel of members of the UKMS Executive Committee and applicants will be notified of the outcome of the competition by the end of March 2024 at the latest.

Please note that if you are unable to present your work, then the UKMS reserve the right to withdraw the bursary.

Professor Gordon Cook

Dean of College of Myeloma

Professor of Haematology & Myeloma Studies, Consultant Haematologist

St James Institute of Oncology, Leeds Teaching Hospitals, Leeds, UK

I am a graduate of the University of Glasgow School of Medicine. I received my higher professional training in haematology in the West of Scotland. After completion of my PhD, I was appointed as a consultant Haematologist in the West of Scotland before moving to take up my present post based at Leeds Teaching Hospitals, in 2002.

I run a small peer-review grant-funded basic research group with areas of interests in transplantation and tumour immunology.

I am currently the President of the British Society of Blood & Marrow Transplantation. I represent the transplant society at the Government strategic and national commissioning level. I am a member of the NCRI Haematology-Oncology Clinical Studies Group. I am the secretary of the United Kingdom Myeloma Forum (UKMF) and have represented the interests of myeloma clinicians and patients in NICE reviews. I am a member of the NCRI Haem-Onc Myeloma sub-group and Principal Investigator for NCRI Myeloma X. In addition, I am a Board member of Myeloma UK and Medical Editor of Myeloma Today.